Digest: The Act allows doctors to give some patients novel types of treatment. (Flesch Readability Score: 74.8).
Creates a method by which a health care practitioner may offer to treat a patient who has a terminal disease or severe chronic disease with an investigational product not approved by the United States Food and Drug Administration. Provides protections, including a waiver of liability, for health care practitioners, health care facilities, professional organizations or associations and manufacturers or distributors of investigational products that comply with the Act.